Literature DB >> 24913979

Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis.

Sarah B Simmons1, Denny Liggitt2, Joan M Goverman3.   

Abstract

Multiple sclerosis (MS) is an autoimmune disease in which inflammatory lesions lead to tissue injury in the brain and/or spinal cord. The specific sites of tissue injury are strong determinants of clinical outcome in MS, but the pathways that determine whether damage occurs in the brain or spinal cord are not understood. Previous studies in mouse models of MS demonstrated that IFN-γ and IL-17 regulate lesion localization within the brain; however, the mechanisms by which these cytokines mediate their effects have not been identified. In the present study, we show that IL-17 promoted, but IFN-γ inhibited, ELR(+) chemokine-mediated neutrophil recruitment to the brain, and that neutrophil infiltration was required for parenchymal tissue damage in the brain. In contrast, IFN-γ promoted ELR(+) chemokine expression and neutrophil recruitment to the spinal cord. Surprisingly, tissue injury in the spinal cord did not exhibit the same dependence on neutrophil recruitment that was observed for the brain. Our results demonstrate that the brain and spinal cord exhibit distinct sensitivities to cellular mediators of tissue damage, and that IL-17 and IFN-γ differentially regulate recruitment of these mediators to each microenvironment. These findings suggest an approach toward tailoring therapies for patients with distinct patterns of neuroinflammation.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24913979      PMCID: PMC4123857          DOI: 10.4049/jimmunol.1400807

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease.

Authors:  H Bartosik-Psujek; Z Stelmasiak
Journal:  Eur J Neurol       Date:  2005-01       Impact factor: 6.089

2.  Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.

Authors:  Harald H Hofstetter; Saleh M Ibrahim; Dirk Koczan; Niels Kruse; Andreas Weishaupt; Klaus V Toyka; Ralf Gold
Journal:  Cell Immunol       Date:  2005-12-28       Impact factor: 4.868

3.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

4.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.

Authors:  D Matusevicius; P Kivisäkk; B He; N Kostulas; V Ozenci; S Fredrikson; H Link
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

5.  IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.

Authors:  Stefan Haak; Andrew L Croxford; Katharina Kreymborg; Frank L Heppner; Sandrine Pouly; Burkhard Becher; Ari Waisman
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

6.  Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.

Authors:  M K Storch; A Stefferl; U Brehm; R Weissert; E Wallström; M Kerschensteiner; T Olsson; C Linington; H Lassmann
Journal:  Brain Pathol       Date:  1998-10       Impact factor: 6.508

7.  Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein.

Authors:  J M Greer; R A Sobel; A Sette; S Southwood; M B Lees; V K Kuchroo
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

8.  Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.

Authors:  Sally L Carter; Marcus Müller; Peter M Manders; Iain L Campbell
Journal:  Glia       Date:  2007-12       Impact factor: 7.452

9.  Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis.

Authors:  Jason R Lees; Paul T Golumbek; Julia Sim; Denise Dorsey; John H Russell
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

10.  The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease.

Authors:  Thaddeus Carlson; Mark Kroenke; Praveen Rao; Thomas E Lane; Benjamin Segal
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

View more
  46 in total

1.  GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease.

Authors:  Emily R Pierson; Joan M Goverman
Journal:  JCI Insight       Date:  2017-04-06

2.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors:  Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal:  JCI Insight       Date:  2019-04-02

Review 3.  Neutrophil Recruitment: From Model Systems to Tissue-Specific Patterns.

Authors:  Andreas Margraf; Klaus Ley; Alexander Zarbock
Journal:  Trends Immunol       Date:  2019-06-04       Impact factor: 16.687

Review 4.  Cytokine networks in neuroinflammation.

Authors:  Burkhard Becher; Sabine Spath; Joan Goverman
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

5.  The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.

Authors:  Ella Zeldich; Ci-Di Chen; Robin Avila; Satish Medicetty; Carmela R Abraham
Journal:  J Mol Neurosci       Date:  2015-06-12       Impact factor: 3.444

Review 6.  Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.

Authors:  Yudong Liu; Sara A Gibson; Etty N Benveniste; Hongwei Qin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

7.  Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis.

Authors:  Stephen Blackmore; Jessica Hernandez; Michal Juda; Emily Ryder; Gregory G Freund; Rodney W Johnson; Andrew J Steelman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

8.  Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity.

Authors:  Catriona A Wagner; Pamela J Roqué; Trevor R Mileur; Denny Liggitt; Joan M Goverman
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

9.  Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.

Authors:  Mohammad Sajad Emami Aleagha; Mohammad Hossein Harirchian; Shahram Lavasani; Mohammad Javan; Abdolamir Allameh
Journal:  J Mol Neurosci       Date:  2018-03-14       Impact factor: 3.444

10.  Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.

Authors:  Sarah E Lutz; Julian R Smith; Dae Hwan Kim; Carl V L Olson; Kyle Ellefsen; Jennifer M Bates; Sunil P Gandhi; Dritan Agalliu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.